Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Clinical trial NCT00955409 · COMPLETED
Trial details
- NCT number
- NCT00955409
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-05
- Primary completion
- 2013-12-17
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.